Dr Reddy's Laboratories Ltd (STU:RDDA)
€ 13.3 -0.2 (-1.48%) Market Cap: 11.08 Bil Enterprise Value: 10.96 Bil PE Ratio: 23.15 PB Ratio: 3.28 GF Score: 90/100

Q1 2023 Dr Reddy's Laboratories Ltd Earnings Call Transcript

Jul 28, 2022 / 01:00PM GMT
Release Date Price: €10.5
Operator

Ladies and gentlemen, good day, and welcome to Dr. Reddy's Q1 FY '23 Earnings Conference Call. (Operator Instructions). Please note that this conference is being recorded. I now hand the conference over to Mr. Amit Agarwal. Thank you, and over to you, sir.

Amit Agarwal;s Laboratories Limited;Head of IR and Director of Finance
Dr. Reddy;FP&A & IR

'- -

A very good morning, and good evening to all of you, and thank you for joining us today for the Dr. Reddy's earnings conference call for the quarter ended June 30, 2022.

Earlier during the day, we have released our results and the same are also posted on our website. This call is being recorded, and the playback and transcripts will be made available on our website too. All the discussions and analysis of this call will be based on the IFRS consolidated financial statements.

To discuss the business performance and outlook, we have the leadership team of Dr. Reddy comprising Mr. Erez Israeli, our CEO; Mr. Parag Agarwal, our CFO; and the Investor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot